What Does Bollinger Band say about ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP)?

61

Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) for the period of 9-Day stands at 7.77% while the stochastic %D for the same period stands at 8.23%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Buy” for ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP)’s 20-Day Bollinger Band indicates “Sell”.

About Company

ZIOPHARM Oncology, Inc. is a biopharmaceutical company engaged in the development and commercialization of a diverse, risk-sensitive portfolio of in-licensed cancer drugs to address unmet medical needs. The Company applies new insights from molecular and cancer biology to understand the efficacy and safety limitations of approved and developmental cancer therapies and identifies proprietary and related molecules for better patient treatment.

Previous Day Activity Analysis

On the last trading day, ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) opened the session at $5.71 and after going down -2.63% closed at $5.55. The stock lost -0.16 points in the last trade.

ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP)’s stock fluctuated in the range of $5.55 and $5.75 during the previous active session. ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) traded with the volume of 1.05 Million with average volume of 1.05 Million. The stock has HIGH volatility on the last trading session.

Currently the Beta for the company remains at 1.54 while ATR (Average True Range) and RSI (Relative Strength Index) are at 0.24 and 37.7 respectively.

Currently the Insider Ownership of the shares of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) is at 1.5% and the shares outstanding are 145.8 Million.

Important Ratio Analysis

Some important ratios to consider here for ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) are discussed below:

Dividend yield of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The PEG ratio (Price to Earning to Growth) emits the value of 0. The Price to Sale P/S and Price to Book P/B shows the value of 126.44 and 0 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 8.33 and 0 correspondingly.

The Quick Ratio of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) stands at 7.8 while the Current Ratio depicts the value of 7.8.

Return on Assets ROA of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) is at -59.9% whereas, Return on Equity ROE and Return of Investment ROI of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) stand at 88.5% and 213.9% respectively.

Stock Performance Analysis

The stock performance of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) on the basis of 5 day trade show the dip of -11.48% whereas, the monthly performance of the stock shows decrease of -7.35%.

The quarterly performance of the stock remained in red zone with the value of -5.29% while six month performance of the shares of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) remained bearish with the count of -21.5%.

The yearly and YTD performance of ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) remained up at 6.32% and 3.74% respectively.